The new study published in Nature Genetics unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin. The results could help to improve early detection of emerging artemisinin resistance.
Genetics underpinning artemisinin resistance revealed
2 February 2015
NDM researchers have led the largest genome-wide association study to date of the malaria parasite Plasmodium falciparum.